Dear Voornaam Welcome to your weekly Cancer Research UK Research Update email. Congratulations to the winners of the Cancer Research Horizons' Innovation and Entrepreneurship awards: Entrepreneurship Recognition Award: Steve Jackson Impact Recognition Award: Rebecca Fitzgerald Early-career Entrepreneur of the Year: Anjui Wu, Cansor Ltd and Susanti Susanti, PathGen Diagnostik Teknologi Woman Entrepreneur of the Year: Claire Lewis, University of Sheffield New Startup of the Year: Adendra Therapeutics Ltd Startup Achievement of the Year: Achilles Therapeutics Further, Faster, Together: The iDx Lung Collaboration Sixty nominees and guests, drawn from across the entrepreneurial pathway, gathered to hear the awards announced by Andy Richards, Cancer Research Horizons Non-Executive Director. The Recognition category winners, Steve Jackson and Rebecca Fitzgerald spoke candidly about the highs and lows of entrepreneurship, and the importance of collaboration. There was a fantastic buzz throughout, with entrepreneurs sat shoulder-to-shoulder, swapping stories and congratulations across the evening. Follow #IEAwards22 on Twitter and LinkedIn to see photos of the event and to learn more about the winners. |
|
---|
|
---|
|
|
Funding & Research Opportunities |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
|
|
STAY UP TO DATE WITH ENTREPRENEURIAL OPPORTUNITIES Are you interested in drug translation or spinning out a company? Do you have an innovation you are working on? Our innovation engine, Cancer Research Horizons, is rolling out a dedicated newsletter for our entrepreneurially-minded research community. Sign up to hear more about development and accelerator programmes, funding opportunities, and the latest enterprising efforts in oncology. |
|
---|
|
---|
|
|
USING VIRTUAL REALITY TO ANALYSE TUMOURS In 2017, IMAXT was awarded 20 million by Cancer Grand Challenges, funded by Cancer Research UK to map the molecular and cellular tumour microenvironment. The team has now built the first 3D tumour visualisation tool and is releasing their virtual reality software to the wider cancer research community. The tools, created by Suil, will be available for free for academic non-commercial research to enrich the visualisation of huge datasets and gain a greater understanding of the genetics of cancers and the physical structure of tumours. |
|
---|
|
---|
|
|
THE MADNESS OF THE SHORT METHOD SECTION In the latest release of our research integrity series, Dr Andrew Porter (Research Integrity and Training Adviser at the Cancer Research UK Manchester Institute) reveals what we can learn from the Great British Bake Off about the communication of research methods in publications. Andrew explores why adding more detail to the method section is considered a 'taboo', the dangers of publishing with a short method, and he provides takeaway tips on how to reverse the trend. |
|
---|
| JOIN A LEADERSHIP PROGRAMME FOR BLACK, ASIAN AND ETHNICALLY DIVERSE RESEARCHERS StellarHE is recruiting its 2023 cohort of people aspiring to become leaders in higher education and were sponsoring Cancer Research UK-funded researchers to take part. If youre a mid- to senior level researcher, or a senior postdoc aspiring to establish your independence as a research group leader, and from a Black, Asian or ethnically diverse background, you might be eligible to take part. Email us to express your interest by 20 December. |
|
---|
|
---|
|
|
FREE LEADERSHIP COACHING FOR CANCER RESEARCHERS Are you a Cancer Research UK-funded scientist looking to level up your research career? If so, the leadership coaching programme we offer in partnership with Meyler Campbell might be the right fit for you. The programme pairs you with an executive coach who will help you identify and work on your goals. Dont miss out on this valuable opportunity to accelerate your professional and personal development. |
|
---|
| ANSWERING YOUR QUESTIONS ON THE BIOLOGY TO PREVENTION AWARD In our recent webinar, David Crosby (Head of Prevention and Early Detection Research), Professors Kay-Tee Khaw and Karen Brown (Chair and Vice-chair of the Prevention and Population Research Committee) highlighted the need to build on our existing prevention research community and to bring new expertise into the field. They also shared the key components of making a successful application to our Biology to Prevention Award. Applications to this scheme close on 12 January 2023. |
|
---|
|
---|
|
|
WEBINAR ON COLLABORATION AND ADVOCACY IN A RARE CANCER STUDY Join David Thomas from the International Rare Cancers Initiative at 9am GMT on 14 December to hear more about the Molecular Screening and Therapeutics study. This study aims to improve access for targeted treatments to people affected by rare cancers through genomic profiling. David will share his experiences of developing working relationships with pharmaceutical companies and outline different models of interaction between clinical research teams, government, pharma, patient advocates and the public. |
|
---|
| SHARING THE LATEST IN BREAST CANCER RESEARCH The Cancer Research UK Cambridge Centre is hosting its first symposium on Precision Breast Cancer, opening with keynotes from Judy Garber (Dana-Farber Cancer Institute) and Ramona Woitek (Danube Private University). The programme will cover the latest developments in laboratory and clinical research, challenges in clinical practice, unanswered questions, and future directions. Join in person for an opportunity to connect and debate with fellow researchers on 10 February 2023 in Cambridge. |
|
---|
|
---|
|
|
| Online 8:00 AM 14 December 2022 |
|
---|
|
---|
| London, UK 25 January 2023 |
|
---|
|
---|
| Cambridge, UK 9:00 AM 10 February 2023 |
|
---|
|
---|
| London, UK 10 October 2023 |
|
---|
|
---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
---|
|
---|
|
|
Been forwarded this email? Subscribe to our newsletter to stay up-to-date. |
---|
| |
---|
|
|
|